| Time | Topic |
|---|---|
| 7:00 a.m. | Continental Breakfast |
| 8:00 a.m. | Natalizumab Therapy: Risk Stratification, IRIS, and Transition to Other Therapies Orhun H. Kantarci, M.D. |
| 8:45 a.m. | Oral MS Disease-Modifying Therapies B. Mark Keegan, M.D. |
| 9:30 a.m. | Break |
| 9:45 a.m. | Monoclonal Antibodies for MS Jonathan L. Carter, M.D. |
| 10:30 a.m. | Symptomatic and CAM Therapies in MS Elizabeth Shuster, M.D. |
| 11:15 a.m. | Question and Answer Session with Faculty |
| Noon | Lunch |
| 1:00 p.m. | Beyond MS: Autoimmune Neurological Disorders Sean J. Pittock, M.D. and Andrew McKeon, M.D. |
| 2:00 p.m. | Remyelination and Repair Strategies for MS Moses Rodriguez, M.D. |
| 2:30 p.m. | Break |
| 2:45 p.m. | Update on Neuromyelitis Optica Dean M. Wingerchuk, M.D. |
| 3:30 p.m. | Case Vignettes and Faculty Discussion Faculty |
| 4:15 p.m. | Adjourn |
